智通财经APP讯，药明巨诺-B(02126)公布，于2025年1月6日，(i)根据2020年10月14日采纳的公司首次公开发售后激励计划的条款将合共 387,740份购股权;及(ii)根据2020年10月14日采纳的公司首次公开发售后受限制股份单位计划将合共77,548个受限制股份单位，授予两名承授人。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.